Association between myosteatosis or sarcopenia based on abdominal CT and hypertension in systemic lupus erythematosus patients
- PMID: 40114114
- PMCID: PMC11924695
- DOI: 10.1186/s12944-025-02530-9
Association between myosteatosis or sarcopenia based on abdominal CT and hypertension in systemic lupus erythematosus patients
Erratum in
-
Correction: Association between myosteatosis or sarcopenia based on abdominal CT and hypertension in systemic lupus erythematosus patients.Lipids Health Dis. 2025 Apr 16;24(1):141. doi: 10.1186/s12944-025-02564-z. Lipids Health Dis. 2025. PMID: 40240885 Free PMC article. No abstract available.
Abstract
Background: Hypertension and obesity are common in systemic lupus erythematosus (SLE) patients, with obesity-related changes potentially driving hypertension. However, the specific adiposity measures associated with hypertension in SLE patients remain unclear. This study assessed the association between myosteatosis and sarcopenia detected on abdominal CT and hypertension in SLE patients. Mediators of the association between myosteatosis and hypertension were also investigated.
Methods: This was a retrospective study involving SLE patients enrolled from January 2017 to August 2023 and who underwent abdominal CT at the L3 level to track myosteatosis and sarcopenia based on the skeletal muscle mean radiodensity (SMD) and skeletal muscle index considered as binary and continuous variables. The association between these body composition measures and hypertension was tested using logistic regression analyses, while mediation modeling was used to assess the mediators.
Results: A total of 279 adult SLE patients (median age, 41.00 [30.00, 51.00] years; 245 women) were included in this study. Hypertension was associated with myosteatosis (adjusted OR: 3.54; 95% CI: 1.18-10.61 for the binary variable and 1.31; 95% CI: 1.02-1.68 for the continuous variable). No statistically significant association was observed between hypertension and sarcopenia (adjusted OR: 0.48; 95%CI: 0.23-1.01 for the binary variable and 0.95; 95%CI: 0.78-1.16 for the continuous variable). Mediation analyses revealed eGFR could mediate the association between myosteatosis (considered as a continuous variable) and hypertension in SLE patients when taken alone (95% CI: 0.0177-0.2765) or in combination with the TyG index (95% CI: 0.0032-0.0614).
Conclusions: Myosteatosis was associated with hypertension in SLE patients. eGFR alone or in combination with the TyG index may mediate this association.
Keywords: Body composition; Hypertension; Myosteatosis; Sarcopenia; Systemic lupus erythematosus.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This retrospective study was approved by our Ethics Committee and the requirement for informed consent was waived (KYLL-202307-043). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.J Urol. 2021 Mar;205(3):800-805. doi: 10.1097/JU.0000000000001428. Epub 2020 Oct 20. J Urol. 2021. PMID: 33080148 Free PMC article.
-
Varying clinical relevance of sarcopenia and myosteatosis according to age among patients with postoperative colorectal cancer.J Nutr Health Aging. 2024 Jul;28(7):100243. doi: 10.1016/j.jnha.2024.100243. Epub 2024 Apr 20. J Nutr Health Aging. 2024. PMID: 38643603
-
Age-related changes in muscle quality and development of diagnostic cutoff points for myosteatosis in lumbar skeletal muscles measured by CT scan.Clin Nutr. 2021 Jun;40(6):4022-4028. doi: 10.1016/j.clnu.2021.04.017. Epub 2021 Apr 17. Clin Nutr. 2021. PMID: 34144412
-
Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review.J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1671-1678. doi: 10.1093/gerona/glz034. J Gerontol A Biol Sci Med Sci. 2019. PMID: 30726878 Free PMC article.
-
Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.Ann Surg Oncol. 2018 May;25(5):1381-1394. doi: 10.1245/s10434-018-6395-8. Epub 2018 Feb 27. Ann Surg Oncol. 2018. PMID: 29488190 Review.
Cited by
-
Correction: Association between myosteatosis or sarcopenia based on abdominal CT and hypertension in systemic lupus erythematosus patients.Lipids Health Dis. 2025 Apr 16;24(1):141. doi: 10.1186/s12944-025-02564-z. Lipids Health Dis. 2025. PMID: 40240885 Free PMC article. No abstract available.
References
-
- Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15–29. - PubMed
-
- Gavilán-Carrera B, Ruiz-Cobo A, Amaro-Gahete FJ, Soriano-Maldonado A, Vargas-Hitos JA. No changes in body composition and adherence to the mediterranean diet after a 12-Week aerobic training intervention in women with systemic lupus erythematosus: the EJERCITA-LES study. Nutrients. 2023;15(20). - PMC - PubMed
-
- Munguia-Realpozo P, Mendoza-Pinto C, Sierra Benito C, Escarcega RO, Garcia-Carrasco M, Mendez Martinez S, et al. Systemic lupus erythematosus and hypertension. Autoimmun Rev. 2019;18(10):102371. - PubMed
-
- Lu X, Wang Y, Zhang J, Pu D, Hu N, Luo J, et al. Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and Meta-analysis. Int Immunopharmacol. 2021;94:107466. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous